Dr. Jeffrey M. Stewart
Claim this profileGarnet Health Medical Center
Studies Prostate Cancer
Studies Cancer
14 reported clinical trials
29 drugs studied
Area of expertise
1Prostate Cancer
Stage IV
BRCA1 positive
BRCA2 positive
2Cancer
Stage IV
Stage III
Stage I
Affiliated Hospitals
Clinical Trials Jeffrey M. Stewart is currently running
Symptom Monitoring
for Young Women on Hormone Therapy
This phase III trial compares the effect of active symptom monitoring and patient education to patient education alone in helping young women with stage I-III breast cancer stay on their hormone therapy medicines. The patient education tool contains interactive weblinks which provide patients with education material about breast cancer and side effects of therapy. Symptom monitoring is a weblink via email or text message with questions asking about symptoms. Hormone therapy for breast cancer can cause side effects, and may cause some women to stop treatment early. Asking about symptoms more often may help women keep taking hormone therapy medicines.
Recruiting1 award N/A13 criteria
Pembrolizumab + TKI
for Chronic Myeloid Leukemia
This phase II trial studies how well pembrolizumab and dasatinib, imatinib mesylate, or nilotinib work in treating patients with chronic myeloid leukemia and persistent detection of minimal residual disease, defined as the levels of a gene product called bcr-abl in the blood. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of cancer cells to grow and spread. Dasatinib, imatinib mesylate, and nilotinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving pembrolizumab and dasatinib, imatinib mesylate, or nilotinib may work better in treating patients with chronic myeloid leukemia.
Recruiting1 award Phase 2
More about Jeffrey M. Stewart
Clinical Trial Related4 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Jeffrey M. Stewart has experience with
- Pembrolizumab
- Carboplatin
- Durvalumab
- Intensity-Modulated Radiation Therapy (IMRT)
- Stereotactic Body Radiation Therapy (SBRT)
- Dasatinib
Breakdown of trials Jeffrey M. Stewart has run
Prostate Cancer
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeffrey M. Stewart specialize in?
Jeffrey M. Stewart focuses on Prostate Cancer and Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are BRCA1 positive.
Is Jeffrey M. Stewart currently recruiting for clinical trials?
Yes, Jeffrey M. Stewart is currently recruiting for 9 clinical trials in Middletown New York. If you're interested in participating, you should apply.
Are there any treatments that Jeffrey M. Stewart has studied deeply?
Yes, Jeffrey M. Stewart has studied treatments such as Pembrolizumab, Carboplatin, Durvalumab.
What is the best way to schedule an appointment with Jeffrey M. Stewart?
Apply for one of the trials that Jeffrey M. Stewart is conducting.
What is the office address of Jeffrey M. Stewart?
The office of Jeffrey M. Stewart is located at: Garnet Health Medical Center, Middletown, New York 10940 United States. This is the address for their practice at the Garnet Health Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.